Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma

doi:10.1084/jem.181.1.33

This Article

	Full Text (PDF)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Leung, D. Y.
	Articles by Hamid, Q.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Leung, D. Y.
	Articles by Hamid, Q.


Social Bookmarking

	What's this?

ARTICLES

Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma

DY Leung, RJ Martin, SJ Szefler, ER Sher, S Ying, AB Kay and Q Hamid
Department of Pediatrics, National Jewish Center for Immunology and Respiratory Medicine, Denver, Colorado 80206.

In steroid-resistant (SR) asthma, there is a lack of clinical responsiveness to oral prednisone. Previous studies indicate that this may be explained by the effect of the combination of interleukin 2 (IL- 2) and IL-4 on glucocorticoid receptor binding affinity. By contrast, steroid-sensitive (SS) asthmatics respond well to glucocorticoids, and this is accompanied by a decrease in the numbers of bronchoalveolar lavage (BAL) messenger RNA+ (mRNA+) cells expressing IL-4 and IL-5, and an increase in interferon gamma (IFN-gamma) transcripts. In the present study, we hypothesized that SR asthma is associated with alterations in T helper types 1/2 (Th2/Th1)-type cytokine gene expression. BAL was performed in six SR asthmatics and six SS asthmatics, before and after a 1-wk course of 40 mg daily prednisone. mRNA+ cells for IL-2, IL-4, IL- 5, and IFN-gamma was measured by in situ hybridization using 35S- labeled RNA probes. Before prednisone therapy, there were significantly greater numbers of BAL cells (per 1,000) expressing IL-2 mRNA (p < 0.01) and IL-4 mRNA (p < 0.05) in SR asthmatics as compared with SS asthmatics, but no differences between the two groups in the numbers of BAL cells expressing IFN-gamma or IL-5 mRNA expression were observed. After a 1-wk course of prednisone, IL-2 expression was not altered in either group. However, SS asthmatics had a significant decrease in the numbers of BAL cells expressing mRNA for IL-4 (p < 0.01) and IL-5 (p < 0.001), and a rise in the numbers of IFN-gamma mRNA+ cells (p < 0.01). In contrast, after prednisone treatment, SR asthmatics had no significant change in either the number of BAL cells expressing mRNA for IL-4 or IL-5. Of note, there was an unexpected decrease in the numbers of IFN-gamma mRNA+ cells (p = 0.05). Our current findings indicate that SR asthma is associated with a dysregulation of the expression of the genes encoding for Th2/Th1 cytokines in airway cells and is compatible with the concept that a combination of IL-2 and IL-4 induce glucocorticoid (GR) binding affinity and T cell responsiveness to glucocorticoids.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Lee, R. W. J., Creed, T. J., Schewitz, L. P., Newcomb, P. V., Nicholson, L. B., Dick, A. D., Dayan, C. M. (2007). CD4+CD25int T Cells in Inflammatory Diseases Refractory to Treatment with Glucocorticoids. J. Immunol. 179: 7941-7948 [Abstract] [Full Text]
Lajoie-Kadoch, S., Joubert, P., Letuve, S., Halayko, A. J., Martin, J. G., Soussi-Gounni, A., Hamid, Q. (2006). TNF-{alpha} and IFN-{gamma} inversely modulate expression of the IL-17E receptor in airway smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 290: L1238-L1246 [Abstract] [Full Text]
Barnes, P. J. (2006). Corticosteroid effects on cell signalling. Eur Respir J 27: 413-426 [Abstract] [Full Text]
Georas, S. N., Guo, J., De Fanis, U., Casolaro, V. (2005). T-helper cell type-2 regulation in allergic disease. Eur Respir J 26: 1119-1137 [Abstract] [Full Text]
Peek, E. J., Richards, D. F., Faith, A., Lavender, P., Lee, T. H., Corrigan, C. J., Hawrylowicz, C. M. (2005). Interleukin-10-Secreting "Regulatory" T Cells Induced by Glucocorticoids and {beta}2-Agonists. Am. J. Respir. Cell Mol. Bio. 33: 105-111 [Abstract] [Full Text]
Federico, M. J., Covar, R. A., Brown, E. E., Leung, D. Y. M., Spahn, J. D. (2005). Racial Differences in T-Lymphocyte Response to Glucocorticoids. Chest 127: 571-578 [Abstract] [Full Text]
Barnes, P. J. (2004). Corticosteroid Resistance in Airway Disease. Proc Am Thorac Soc 1: 264-268 [Abstract] [Full Text]
Payne, D N R, Qiu, Y, Zhu, J, Peachey, L, Scallan, M, Bush, A, Jeffery, P K (2004). Airway inflammation in children with difficult asthma: relationships with airflow limitation and persistent symptoms. Thorax 59: 862-869 [Abstract] [Full Text]
Djukanovic, R., Wilson, S. J., Kraft, M., Jarjour, N. N., Steel, M., Chung, K. F., Bao, W., Fowler-Taylor, A., Matthews, J., Busse, W. W., Holgate, S. T., Fahy, J. V. (2004). Effects of Treatment with Anti-immunoglobulin E Antibody Omalizumab on Airway Inflammation in Allergic Asthma. Am. J. Respir. Crit. Care Med. 170: 583-593 [Abstract] [Full Text]
Gardai, S. J., Hoontrakoon, R., Goddard, C. D., Day, B. J., Chang, L. Y., Henson, P. M., Bratton, D. L. (2003). Oxidant-Mediated Mitochondrial Injury in Eosinophil Apoptosis: Enhancement by Glucocorticoids and Inhibition by Granulocyte-Macrophage Colony-Stimulating Factor. J. Immunol. 170: 556-566 [Abstract] [Full Text]
Goleva, E., Kisich, K. O., Leung, D. Y. M. (2002). A Role for STAT5 in the Pathogenesis of IL-2-Induced Glucocorticoid Resistance. J. Immunol. 169: 5934-5940 [Abstract] [Full Text]
Wood, L. J., Sehmi, R., Dorman, S., Hamid, Q., Tulic, M. K., Watson, R. M., Foley, R., Wasi, P., Denburg, J. A., Gauvreau, G., O'Byrne, P. M. (2002). Allergen-induced Increases in Bone Marrow T Lymphocytes and Interleukin-5 Expression in Subjects with Asthma. Am. J. Respir. Crit. Care Med. 166: 883-889 [Abstract] [Full Text]
GALON, J., FRANCHIMONT, D., HIROI, N., FREY, G., BOETTNER, A., EHRHART-BORNSTEIN, M., O'SHEA, J. J., CHROUSOS, G. P., BORNSTEIN, S. R. (2002). Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J. 16: 61-71 [Abstract] [Full Text]
KURASHIMA, K., FUJIMURA, M., MYOU, S., KASAHARA, K., TACHIBANA, H., AMEMIYA, N., ISHIURA, Y., ONAI, N., MATSUSHIMA, K., NAKAO, S. (2001). Effects of Oral Steroids on Blood CXCR3+ and CCR4+ T Cells in Patients with Bronchial Asthma. Am. J. Respir. Crit. Care Med. 164: 754-758 [Abstract] [Full Text]
Wenzel, S. (2000). Proceedings of the ATS Workshop on Refractory Asthma . Current Understanding, Recommendations, and Unanswered Questions. Am. J. Respir. Crit. Care Med. 162: 2341-2351 [Full Text]
LEUNG, D. Y. M., CHROUSOS, G. P. (2000). Is There a Role for Glucocorticoid Receptor Beta in Glucocorticoid-dependent Asthmatics?. Am. J. Respir. Crit. Care Med. 162: 1-3 [Full Text]
Chen, R., Burke, T. F., Cumberland, J. E., Brummet, M., Beck, L. A., Casolaro, V., Georas, S. N. (2000). Glucocorticoids Inhibit Calcium- and Calcineurin-Dependent Activation of the Human IL-4 Promoter. J. Immunol. 164: 825-832 [Abstract] [Full Text]
LOUIS, R., LAU, L. C. K., BRON, A. O., ROLDAAN, A. C., RADERMECKER, M. (2000). The Relationship between Airways Inflammation and Asthma Severity. Am. J. Respir. Crit. Care Med. 161: 9-16 [Abstract] [Full Text]
JATAKANON, A., UASUF, C., MAZIAK, W., LIM, S., CHUNG, K. F., BARNES, P. J. (1999). Neutrophilic Inflammation in Severe Persistent Asthma. Am. J. Respir. Crit. Care Med. 160: 1532-1539 [Abstract] [Full Text]
Pariante, C. M., Pearce, B. D., Pisell, T. L., Sanchez, C. I., Po, C., Su, C., Miller, A. H. (1999). The Proinflammatory Cytokine, Interleukin-1{alpha}, Reduces Glucocorticoid Receptor Translocation and Function. Endocrinology 140: 4359-4366 [Abstract] [Full Text]
WENZEL, S. E., SCHWARTZ, L. B., LANGMACK, E. L., HALLIDAY, J. L., TRUDEAU, J. B., GIBBS, R. L., CHU, H. W. (1999). Evidence That Severe Asthma Can Be Divided Pathologically into Two Inflammatory Subtypes with Distinct Physiologic and Clinical Characteristics. Am. J. Respir. Crit. Care Med. 160: 1001-1008 [Abstract] [Full Text]
Chung, K F, Barnes, P J (1999). Cytokines in asthma. Thorax 54: 825-857 [Full Text]
Yoshikawa, H., Nakajima, Y., Tasaka, K. (1999). Glucocorticoid Suppresses Autocrine Survival of Mast Cells by Inhibiting IL-4 Production and ICAM-1 Expression. J. Immunol. 162: 6162-6170 [Abstract] [Full Text]
HAMID, Q.�A., WENZEL, S.�E., HAUK, P.�J., TSICOPOULOS, A., WALLAERT, B., LAFITTE, J.-J., CHROUSOS, G.�P., SZEFLER, S.�J., LEUNG, D.�Y.�M. (1999). Increased Glucocorticoid Receptor beta �in Airway Cells of Glucocorticoid-insensitive Asthma. Am. J. Respir. Crit. Care Med. 159: 1600-1604 [Abstract] [Full Text]
Xiong, Y., Karupiah, G., Hogan, S. P., Foster, P. S., Ramsay, A. J. (1999). Inhibition of Allergic Airway Inflammation in Mice Lacking Nitric Oxide Synthase 2. J. Immunol. 162: 445-452 [Abstract] [Full Text]
Barnes, P. J., Chung, K. F., Page, C. P. (1998). Inflammatory Mediators of Asthma: An Update. Pharmacol. Rev. 50: 515-596 [Abstract] [Full Text]
Wu, C.-Y., Wang, K., McDyer, J. F., Seder, R. A. (1998). Prostaglandin E2 and Dexamethasone Inhibit IL-12 Receptor Expression and IL-12 Responsiveness. J. Immunol. 161: 2723-2730 [Abstract] [Full Text]
Okada, S., Hagan, J. B., Kato, M., Bankers-Fulbright, J. L., Hunt, L. W., Gleich, G. J., Kita, H. (1998). Lidocaine and its Analogues Inhibit IL-5-Mediated Survival and Activation of Human Eosinophils. J. Immunol. 160: 4010-4017 [Abstract] [Full Text]
Ayres, J. G, Miles, J. F, Barnes, P. J (1998). Brittle asthma. Thorax 53: 315-321 [Full Text]
BARNES, P.�J., PEDERSEN, S., BUSSE, W.�W. (1998). Efficacy and Safety of Inhaled Corticosteroids . New Developments. Am. J. Respir. Crit. Care Med. 157: S1-53 [Full Text]
DeKruyff, R. H., Fang, Y., Umetsu, D. T. (1998). Corticosteroids Enhance the Capacity of Macrophages to Induce Th2 Cytokine Synthesis in CD4+ Lymphocytes by Inhibiting IL-12 Production. J. Immunol. 160: 2231-2237 [Abstract] [Full Text]
Leung, D. Y.M., Hamid, Q., Vottero, A., Szefler, S. J., Surs, W., Minshall, E., Chrousos, G. P., Klemm, D. J. (1997). Association of Glucocorticoid Insensitivity with Increased Expression of Glucocorticoid Receptor beta �. J. Exp. Med. 186: 1567-1574 [Abstract] [Full Text]
Laberge, S., Ernst, P., Ghaffar, O., Cruikshank, W. W., Kornfeld, H., Center, D. M., Hamid, Q. (1997). Increased Expression of Interleukin-16 in Bronchial Mucosa of Subjects with Atopic Asthma. Am. J. Respir. Cell Mol. Bio. 17: 193-202 [Abstract] [Full Text]